The -1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: A meta-analysis

Cytokine

Volumn 56, Issue 2, 2011, Pages 351-355

  Zhang, Jie ^a   Zhang, Yonggang ^b   Jin, Jing ^a   Li, Min ^a   Xie, Kejian ^a   Wen, Chaowei ^a   Cheng, Ruiping ^a   Chen, Cong ^a   Lu, Jianxi ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Interleukin 10; Meta analysis; Polymorphism; Rheumatoid arthritis

Indexed keywords

ARTICLE; CASE CONTROL STUDY; EUROPE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTERLEUKIN 10 GENE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC;

EID: 80053337731     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.022     Document Type: Article

References (32)

1. Eskdale J., McNicholl J., Wordsworth P., Jonas B., Huizinga T., Field M., et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998, 352:1282-1283.
2. Bronson P.G., Criswell L.A., Barcellos L.F. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis 2008, 67:933-936.
3. Flytlie H.A., Hvid M., Lindgreen E., Kofod-Olsen E., Petersen E.L., Jorgensen A., et al. Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine 2010, 49:24-29.
4. Perdigones N., Lamas J.R., Vigo A.G., de la Concha E.G., Jover J.A., Urcelay E., et al. 6q23 polymorphisms in rheumatoid arthritis Spanish patients. Rheumatology (Oxford) 2009, 48:618-621.
5. Nemec P., Pavkova-Goldbergova M., Gatterova J., Fojtik Z., Vasku A., Soucek M. Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis. Clin Rheumatol 2009, 28:899-905.
6. Kochi Y., Okada Y., Suzuki A., Ikari K., Terao C., Takahashi A., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010, 42:515-519.
7. Pavy S., Toonen E.J., Miceli-Richard C., Barrera P., van Riel P.L., Criswell L.A., et al. Systematic review and meta-analysis. Ann Rheum Dis 2010, 69:1022-1028.
8. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
9. Gregersen P.K., Amos C.I., Lee A.T., Lu Y., Remmers E.F., Kastner D.L., et al. Encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009, 41:820-823.
10. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008, 40:1216-1223.
11. Pawlik A., Kurzawski M., Szklarz B.G., Herczynska M., Drozdzik M. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 2005, 24:480-484.
12. Munshi A., Rajeshwar K., Kaul S., Al-Hazzani A., Alshatwi A.A., Sai B.M., et al. Interleukin-10 -1082 promoter polymorphism and ischemic stroke risk in a South Indian population. Cytokine 2010, 52:221-224.
13. Schotte H., Schluter B., Drynda S., Willeke P., Tidow N., Assmann G., et al. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 2005, 64:575-581.
14. Ying B., Shi Y., Pan X., Song X., Huang Z., Niu Q., et al. Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol Biol Rep 2010, 10.1007/s11033-010-0119-x.
15. Ji J.D., Kim H.J., Rho Y.H., Choi S.J., Lee Y.H., Cheon H.J., et al. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12, 14-prostaglandin J2. Rheumatology (Oxford) 2005, 44:983-988.
16. Hee C.S., Gun S.C., Naidu R., Gupta E., Somnath S.D., Radhakrishnan A.K. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 2007, 17:429-435.
17. Bartelds G.M., Wijbrandts C.A., Nurmohamed M.T., Wolbink G.J., de Vries N., Tak P.P., et al. Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms. Arthritis Rheum 2009, 60:2541-2542.
18. Won H.H., Kim J.W., Kim M.J., Kim S., Park J.H., Lee K.A. Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians. Cytokine 2010, 51:73-77.
19. Menegatti E., Davit A., Francica S., Berardi D., Rossi D., Baldovino S., et al. Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 2009, 27:217-223.
20. Cantagrel A., Navaux F., Loubet-Lescoulie P., Nourhashemi F., Enault G., Abbal M., et al. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999, 42:1093-1100.
21. Trajkov D., Mishevska-Perchinkova S., Karadzova-Stojanoska A., Petlichkovski A., Strezova A., Spiroski M. Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol 2009, 28:1291-1300.
22. Ates O., Hatemi G., Hamuryudan V., Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol 2008, 27:1243-1248.
23. Paradowska-Gorycka A., Trefler J., Maciejewska-Stelmach J., Lacki J.K. Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients. Int J Immunogenet 2010, 37:225-231.
24. de Paz B., Alperi-Lopez M., Ballina-Garcia F.J., Prado C., Mozo L., Gutierrez C., et al. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis - association with clinical response to glucocorticoids. J Rheumatol 2010, 37:503-511.
25. Padyukov L., Hytonen A.M., Smolnikova M., Hahn-Zoric M., Nilsson N., Hanson L.A., et al. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 2004, 31:422-425.
26. Liu L., Zhuang W., Wang C., Chen Z., Wu X.T., Zhou Y., et al. A meta-analysis of epidemiological studies. Cytokine 2010, 50:328-334.
27. Zhang Y., Zhang J., Huang J., Li X., He C., Tian C., et al. A meta-analysis. Respirology 2010, 15:643-650.
28. Plant D., Thomson W., Lunt M., Flynn E., Martin P., Eyre S., et al. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford) 2010, 10.1093/rheumatology/keq032.
29. Kelley J.M., Hughes L.B., Malik A., Danila M.I., Edberg Y., Alarcon G.S., et al. Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans. Ann Rheum Dis 2010, 69:625-626.
30. Bowes J., Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008, 47:399-402.
31. Martinez A., Pascual M., Pascual-Salcedo D., Balsa A., Martin J., de la Concha E.G., et al. An association and linkage study. Genes Immun 2003, 4:117-121.
32. Qiu L.X., Li R.T., Zhang J.B., Zhong W.Z., Bai J.L., Liu B.R., et al. The E-cadherin (CDH1) - 160 C/A polymorphism and prostate cancer risk: a meta-analysis: a meta-analysis. Eur J Hum Genet 2009, 17:244-249.